Transcription elongation in the human c-myc gene is governed by overall transcription initiation levels in Xenopus oocytes.
Both transcription initiation and transcription elongation contribute to the regulation of steady-state c-myc RNA levels. We have used the Xenopus oocyte transcription assay to study premature transcription termination which occurs in the first exon and intron of the human c-myc gene. Previous studies showed that after injection into Xenopus oocytes transcription from the c-myc P1 promoter resulted in read-through transcripts whereas transcription from the stronger P2 promoter resulted in a combination of prematurely terminated and read-through transcripts. We now demonstrate that this promoter-specific processivity results from the overall amount of RNA polymerase II transcription occurring from either promoter. Parameters that reduce the amount of transcription from P1 or P2, such as decreased concentration of template injected or decreased incubation time, result in a reduction in the ratio of terminated to read-through c-myc transcripts. Conversely, when transcription levels are increased by higher concentrations of injected template, increased incubation time, or coinjection with competing template, the ratio of terminated to read-through transcripts increases. We hypothesize that an RNA polymerase II processivity function is depleted above a threshold level of transcription initiation, resulting in high levels of premature transcription termination. These findings account for the promoter-specific effects on transcription elongation previously seen in this assay system and suggest a mechanism whereby limiting transcription elongation factors may contribute to transcription regulation in other eukaryotic cells.
Spencer
C A
CA
Department of Biochemistry, University of Alberta, Edmonton, Canada.
Kilvert
M A
MA
D000818:Animals; D002478:Cells, Cultured; D003001:Cloning, Molecular; D016259:Genes, myc; D006801:Humans; D009865:Oocytes / Q000378:metabolism; D010957:Plasmids; D011401:Promoter Regions, Genetic; D012319:RNA Polymerase II / Q000378:metabolism; D015183:Restriction Mapping; D013698:Templates, Genetic; D013728:Terminator Regions, Genetic; D013997:Time Factors; D014158:Transcription, Genetic; D014982:Xenopus laevis
D012319:RNA Polymerase II